|
Sr. No. |
Product |
Formulation |
Strength |
Status |
|
1 |
Metformin XR |
Tablets |
500mg, 750mg, 1000mg |
EU CTD Dossier Available |
|
2 |
Sitagliptin |
Tablets |
25mg, 50mg, 100mg |
Prototype Ready |
|
3 |
Sitagliptin, Metformin |
Tablets |
50mg,500mg; 50mg,850mg; |
Prototype Ready |
|
4 |
Sitagliptin, Metformin XR |
Tablets |
50mg,500mg; 50mg,1000mg; |
Prototype Ready |
|
5 |
Dapagliflozin |
Tablets |
5mg, 10mg |
Prototype by Q4 2023 |
|
6 |
Dapagliflozin, Metformin IR |
Tablets |
5mg, 500mg; 5mg, 850mg; 5mg, 1000mg |
Prototype by Q4 2023 |
|
7 |
Dapagliflozin, Metformin XR |
Tablets |
2.5mg, 1000mg ; 5mg, 500mg; 5mg, 1000mg; 10mg, 500mg; 10mg, 1000mg |
Prototype by Q4 2023 |
|
8 |
Topiramate |
Sprinkle Capsule |
15mg, 25mg, 50mg |
Prototype by Q3 2023 |